Ibuprofen is one the most well-known pain medications in the West, taken by millions of people every day. It’s a particular favorite of many athletes who suffer from muscle soreness and joint pains. According to a recent study, however, regular consumption of the drug could lead to several side-effects, including male sterility.
Published in the journal, Proceedings of the National Academy of Sciences, the study looked into the how ibuprofen alters the physiology of testicles after prolonged use. The hormonal changes that it induces is commonly associated with sterility.
“Our study addresses this issue by extending data showing antiandrogen effects of analgesics and suggests that such compounds may be involved in adult male reproductive problems. Using a unique combination of a randomized, controlled clinical trial and ex vivo and in vitro approaches, we report a univocal depression of important aspects of testicular function, including testosterone production, after use of over-the-counter ibuprofen,” the paper reads.
Of course, ibuprofen is only the generic name of the drug. Some of the most popular brand names of it include Advil and Motrin, which are over-the-counter products, CNN reports. It is worth noting that the study is actually a continuation of research looking into the effects of pain relievers on pregnant women.
According to the results of their study, taking aspirin, acetaminophen or ibuprofen during pregnancy can lead to complications with regards to the development of babies. These could include the development of congenital malformations, which is what led the researchers to wonder how the drugs would affect adults.
As Forbes notes, this is the first study to provide evidence with regards to the negative impact of ibuprofen on testicular physiology. No doubt, more research will be conducted to make a more solid conclusion with regards to the effects of the common drug and what people should do about it.


Trump Signs Executive Order to Boost AI Research in Childhood Cancer
NASA and Roscosmos Chiefs Meet in Florida to Discuss Moon and ISS Cooperation
SpaceX Starship Test Flight Reaches New Heights but Ends in Setback
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy
Lost in space: MethaneSat failed just as NZ was to take over mission control – here’s what we need to know now
Neuren Pharmaceuticals Surges on U.S. Patent Win for Rare Disorder Drug
Trump Administration to Launch Autism Initiatives Targeting Acetaminophen Use and New Treatment Options
Neuralink Plans High-Volume Brain Implant Production and Fully Automated Surgery by 2026
SpaceX’s Starship Completes 11th Test Flight, Paving Way for Moon and Mars Missions
Tabletop particle accelerator could transform medicine and materials science
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Trump and Merck KGaA Partner to Slash IVF Drug Costs and Expand Fertility Coverage
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 



